VORHERSAGE DES VIROLOGISCHEN ANSPRECHENS BEI HCV GENOTYP 1A-INFIZIERTEN PATIENTEN ANHAND EINES AMINOSÄURE MUSTERS IM NS5A PROTEIN

Autor: M von Wagner, C Welsch, E Herrmann, C Sarrazin, A Kau, M Welker, C Merkwirth, T Lengauer, JM Pawlotsky, A Neumann, C Ferrari, S Schalm, S Zeuzem

Publikováno v: Zeitschrift für Gastroenterologie. 46

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4e959c0326dfbb33974fe5535252b70c
https://doi.org/10.1055/s-2008-1037596

Chronic hepatitis C virus and gastric MALT lymphoma

Autor: Em, Tkoub, Corinne Haioun, Jm, Pawlotsky, Dhumeaux D, Jc, Delchier

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7dbcb7bb71890a84c709242ecd9b665e
https://pubmed.ncbi.nlm.nih.gov/9414306

Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.

Autor: Fourati S; Department of Virology, Hôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France; Université Paris-Est-Créteil, Créteil, France; INSERM U955, Team Viruses, Hepatology, Cancer, Créteil, France. Electronic address: slim.fourati@aphp.fr., Reslan A; M3P, UMR 1173 (2I), INSERM, Université de Versailles St Quentin, Université Paris Saclay, Paris, France; M3P Centre National de Référence Virus des Infections Respiratoire Institut Pasteur Université Paris Cité, Paris, France., Bourret J; M3P Centre National de Référence Virus des Infections Respiratoire Institut Pasteur Université Paris Cité, Paris, France., Casalegno JS; Laboratoire de Virologie, Institut des Agents Infectieux, Centre de Biologie et Pathologie Nord, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon France, France., Rahou Y; M3P, UMR 1173 (2I), INSERM, Université de Versailles St Quentin, Université Paris Saclay, Paris, France; M3P Centre National de Référence Virus des Infections Respiratoire Institut Pasteur Université Paris Cité, Paris, France., Chollet L; Laboratoire de Biologie Médicale Centre Hospitalier Intercommunal de Toulon, Toulon, France., Pillet S; Service des Agents Infectieux et d'Hygiène-Plateau de Biologie Hôpital Nord-CHU de Saint-Etienne, France, Saint-Etienne, France., Tremeaux P; Laboratoire de Virologie, CHU Toulouse, France, Toulouse France, France., Dossou NC; Normandie, INSERM, Normandie Univ, DYNAMICURE UMR1311, CHU Caen, Department of Virology, Caen, France., Gault E; M3P, UMR 1173 (2I), INSERM, Université de Versailles St Quentin, Université Paris Saclay, Paris, France; Virology Department, Hôpital Ambroise Paré, Paris, France., Salmona M; Virology Department, Hôpital Saint Louis, INSIGHT U976, INSERM, Université Paris-Cité, Paris, France., Imbert-Marcille BM; Virology department, CHU de Nantes, Nantes, France., Mirand A; Virology Department, CHU de Clermont-Ferrand, Clermond-Ferrand, France., Larrat S; Université Grenoble Alpes, Laboratoire de Virologie, Institut de Biologie-Pathologie, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France., Moisan A; Université Rouen Normandie, Université de Caen Normandie, INSERM, Normandie Université, DYNAMICURE UMR 1311, CHU Rouen, Department of Virology, Rouen, France., Marot S; Sorbonne Université; APHP Virologie Pitié-Salpêtrière, Paris Ile de France, France., Schnuriger A; Sorbonne Université, APHP Virologie St Antoine, Tenon, Trousseau, Paris Ile de France, France., Veyrenche N; Virology Department, Hôpital Necker, Enfants Malades, Paris, France., Engelmann I; Pathogenesis and Control of Chronic and Emerging Infections, Université Montpellier, INSERM, Établissement Français du Sang, CHU Montpellier, Montpellier, France., Handala L; Virology Unit, Department of Bacteriology, Virology and Hospital Hygiene, University Hospital of Tours, Tours, France., Henry A; Laboratoire de Biologie Médicale, Microbiologie, CH Victor Dupouy, Argenteuil, France., Stephan V; Virology Department, CHRU de Brest, Brest, France., Brichler S; Service de Microbiologie Clinique, CHU Avicenne, AP-HP, Bobigny, Bobigny, France., Avettand-Fenoel V; CHU Orléans, Virologie, Orléans, France., Zemali N; CHU de Bordeaux, Service de Virologie, Bordeaux, France., Lefeuvre C; Laboratoire de Virologie, CHU Angers, Angers, France., Pronier C; Virology Department, CHU de Rennes, Rennes, France., Deroche L; Virology Department, CHU de Poitiers, Poitiers, France., Jaffar-Bandjee MC; CNR Associé des Virus Respiratoires, laboratoire Microbiologie, Hôpital Félix Guyon CHU Réunion, La Réunion, France., Mouna L; Virology Department, Hôpital Paul Brousse, INSERM U1193, AP-HP, Université Paris Saclay, Paris, France., Francois C; Laboratoire de Virologie, Centre de Biologie Humaine-CHU Amiens, Université Picardie Jules Verne, Amiens, France., Regueme A; Université Lille, CHU de Lille, Laboratoire de Virologie ULR3610, Lille, France., Hartard C; Laboratoire de Virologie, CHRU de Nancy Brabois, Université de LorraineVandœuvre-lès-Nancy, France., Rogez S; Virology Department, CHU de Limoges, Limoges, France., Gallais F; Virology Department, CHU de Strasbourg, Strasbourg, France., Ly A; Department of Virology, Hôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France., Rodriguez C; Department of Virology, Hôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France; Université Paris-Est-Créteil, Créteil, France; INSERM U955, Team Viruses, Hepatology, Cancer, Créteil, France., Dos Santos G; Microbiology Department CHU de Martinique, La Martinique, France., Simon-Loriere E; Evolutionary Genomics of RNA Viruses, Institut Pasteur, Université Paris Cité, Paris, France., Schwartz O; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France., Buchrieser J; Virus and Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France., Pawlotsky JM; Department of Virology, Hôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France; Université Paris-Est-Créteil, Créteil, France; INSERM U955, Team Viruses, Hepatology, Cancer, Créteil, France., Lemoine F; M3P Centre National de Référence Virus des Infections Respiratoire Institut Pasteur Université Paris Cité, Paris, France; Bioinformatics and Biostatistics Hub, Institut Pasteur, Université Paris Cité, Paris, France., Audureau E; Université Paris-Est-Créteil, Créteil, France; Clinical Research Unit Mondor, Hôpitaux Universitaires Henri Mondor, AP-HP, IMRB INSERM U955, Team CEpiA, Créteil, France., Rameix-Welti MA; Virology Department, Hôpital Ambroise Paré, Paris, France. Electronic address: marie-anne.rameix-welti@pasteur.fr.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Oct 14. Date of Electronic Publication: 2024 Oct 14.

Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.

Autor: Marshall AD; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Centre for Social Research in Health, University of New South Wales, Sydney, NSW, Australia. Electronic address: amarshall@kirby.unsw.edu.au., Willing AR; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Kairouz A; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Cunningham EB; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Wheeler A; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., O'Brien N; Macquarie University, Sydney, NSW, Australia., Perera V; Macquarie University, Sydney, NSW, Australia., Ward JW; Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA., Hiebert L; Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA., Degenhardt L; National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia., Hajarizadeh B; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Colledge S; National Drug Research Institute, Curtin University, Perth, WA, Australia., Hickman M; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Jawad D; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Lazarus JV; Barcelona Institute for Global Health (IS Global), Hospital Clinic, University of Barcelona, Barcelona, Spain; CUNY Graduate School of Public Health and Health Policy, New York, NY, USA., Matthews GV; Therapeutic and Vaccine Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; St Vincent's Hospital, Darlinghurst, Sydney, NSW, Australia., Scheibe A; TB HIV Care, Cape Town, South Africa; Community Orientated, Primary Care Research Unit, Department of Family Medicine, University of Pretoria, Pretoria, South Africa., Vickerman P; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Dore GJ; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Grebely J; Viral Hepatitis Clinical Research Program, The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.

Publikováno v: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Apr; Vol. 9 (4), pp. 366-382. Date of Electronic Publication: 2024 Feb 15.

Oral Communication Abstracts.

Publikováno v: Fundamental & Clinical Pharmacology. Apr2017 Supplement, Vol. 31, p5-20. 16p.